ZLD.AX
Price:
$0.65
Market Cap:
$7.38M
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialisation of cannabinoid-based medicines for the treatment of various medical conditions in Australia. It offers formulations under the HOPE brand in Pennsylvania and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia. The company also provides OTC products, including SprinJene, an oral care product; and RAF FIVE, a dermatology product, as well as ITURA, an advanced relief cream formula that targets multi-symptoms, such as numbness and tingling, muscle cramps, insensitivities, and pain associated with Peripheral Artery Disease and di...[Read more]
Industry
Biotechnology
IPO Date
2003-07-25
Stock Exchange
ASX
Ticker
ZLD.AX
According to Zelira Therapeutics Limited’s latest financial reports and current stock price. The company's current Current Ratio is 0.60. This represents a change of -23.26% compared to the average of 0.78 of the last 4 quarters.
The mean historical Current Ratio of Zelira Therapeutics Limited over the last ten years is 19.86. The current 0.60 Current Ratio has changed 202.48% with respect to the historical average. Over the past ten years (40 quarters), ZLD.AX's Current Ratio was at its highest in in the June 2017 quarter at 112.81. The Current Ratio was at its lowest in in the September 2010 quarter at 0.
Average
19.86
Median
4.39
Minimum
0.30
Maximum
112.81
Discovering the peaks and valleys of Zelira Therapeutics Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 37.34%
Maximum Annual Current Ratio = 112.81
Minimum Annual Increase = -95.44%
Minimum Annual Current Ratio = 0.30
Year | Current Ratio | Change |
---|---|---|
2024 | 0.60 | -36.12% |
2023 | 0.94 | -69.87% |
2022 | 3.12 | -44.90% |
2021 | 5.66 | 107.09% |
2020 | 2.73 | -64.36% |
2019 | 7.67 | -86.79% |
2018 | 58.10 | -48.49% |
2017 | 112.81 | 37.34% |
2016 | 0.30 | -95.44% |
2015 | 6.61 | -66.89% |
The current Current Ratio of Zelira Therapeutics Limited (ZLD.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.55
5-year avg
2.61
10-year avg
19.86
Zelira Therapeutics Limited’s Current Ratio is less than Creso Pharma Limited (0.76), less than MGC Pharmaceuticals Limited (0.76), less than Botanix Pharmaceuticals Limited (22.21), greater than Cann Group Limited (0.21), less than Althea Group Holdings Limited (0.64),
Company | Current Ratio | Market cap |
---|---|---|
0.76 | $23.11M | |
0.76 | $18.42M | |
22.21 | $827.02M | |
0.21 | $20.36M | |
0.64 | $13.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zelira Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Zelira Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Zelira Therapeutics Limited's Current Ratio?
How is the Current Ratio calculated for Zelira Therapeutics Limited (ZLD.AX)?
What is the highest Current Ratio for Zelira Therapeutics Limited (ZLD.AX)?
What is the 3-year average Current Ratio for Zelira Therapeutics Limited (ZLD.AX)?
What is the 5-year average Current Ratio for Zelira Therapeutics Limited (ZLD.AX)?
How does the current Current Ratio for Zelira Therapeutics Limited (ZLD.AX) compare to its historical average?